Omicron Boosters Are Coming, But They Weren’t Tested in People. Here’s What You Need to Know
But with the fall and winter fast approaching—the seasons when respiratory viruses like SARS-CoV-2 spread even more efficiently, as students return to school and people huddle indoors—getting the booster ready requires a more efficient review and regulatory process. And that includes considering safety and efficacy data from animals, not people.to consider switching the country to a new booster that targets Omicron, given how quickly that variant is dominating new infections.
Given the short time they had to develop the shot, however, the data only included information on the safety and efficacy of the booster in animals. Human studies are planned and will be ongoing even if the FDA and CDC decide to authorize the shots and the government starts distributing them. The FDA has also decided to review the animal study data without consulting its advisory committee again.
While conducting human studies does take more time, Offit says even a small trial involving about 100 people to measure their antibody levels after getting a BA.4/5 booster would be helpful. “You can boost people and measure their neutralizing antibodies two weeks later,” he says. Such information could also be critical in setting realistic expectations for the Omicron booster.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA Approves First Fast-Acting Drug for Depression That Works Within 1 WeekFDA Approves First Fact-Acting Oral Drug for Clinical Depression That Works in 1 Week
Consulte Mais informação »
Moderna booster application goes to FDA for authorizationThis updated formulation is a bivalent vaccine that will combine the original vaccine with one that targets omicron sublineages BA.4 and BA.5.
Consulte Mais informação »
Trump staffers pushed unproven COVID treatment at FDA: PanelOfficials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment.
Consulte Mais informação »
Moderna booster application goes to FDA for authorizationThis updated formulation is a bivalent vaccine that will combine the original vaccine with one that targets omicron sublineages BA.4 and BA.5.
Consulte Mais informação »
Trump Staffers Pushed Unproven COVID Treatment at FDA, House Report FindsA special House panel looking into the government’s coronavirus response says the Trump White House tried to pressure U.S. health experts into reauthorizing the drug hydroxychloroquine that had been discredited as a COVID-19 treatment.
Consulte Mais informação »
Trump staffers pushed unproven COVID treatment at FDA: PanelOfficials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment.
Consulte Mais informação »